HSPA4 and lung cancer: What’s more, the genetic polymorphism of HSPA4 rs3088225 (A>G) was significantly associated with the progression free survival (PFS) of lung cancer patients in recessive model [p=0.049, OR=0.44; 95%CI, (0.19–1.00)].